Information Library

High-quality studies - Lifecycle Safety

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by:
  • Most Recent
  • Title

  • The New Health Clinical Brochure

    August 31, 2010
    Japanese version available for download.

  • Managing Pharmacovigilance as a Business

    July 28, 2010
    The three steps required to develop a strategic approach to global capacity management.

  • Clinical – smarter trials, accelerated outcomes

    April 2, 2010
    Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues.

  • The Value of Reviewing Existing EU Risk Management Plans

    February 12, 2010
    Drug Safety experts Cheryl Key, Barry Mulchrone and Karen Wai describe an electronic database for tracking RMPs for drugs approved in the European Union and explain why it is crucial for sponsors submitting marketing applications to have a thorough knowledge of safety plans already required for similar products.

  • Patient Registries

    December 11, 2009
    Patient registries services to proof efficacy & safety of drugs through real-life patient data.

  • QUINTILES NAMED BEST CLINICAL SERVICE PROVIDER

    April 23, 2009 - Quintiles was named by industry decision-makers as the most favored contract research organization (CRO), according to two recently released independent surveys.

  • Late Phase and Safety Services

    April 10, 2009
    Recent and pending regulatory changes have created an atmosphere of watchful waiting throughout the industry. While it may seem premature to initiate post-marketing studies to collect more “intelligent” safety data, Quintiles Late Phase & Safety Services anticipates that the need for expanded studies will soon spread.

Page 1 of 1 (7 results)

Subscribe to Email Based on Your Interests

Set preferences